AG Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
Bjørn Heine Strand - NIPH
CIO Bonn - Lymphomzentrum
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
Team | IMMEI
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function
Frontiers | Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells | SpringerLink
Team | IMMEI
UKB NewsRoom | Erfolg bei Ausschreibung „Advanced Clinician Scientist“
Frontiers | Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation
Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy,Journal of Cancer Research and Clinical Oncology - X-MOL
Immunotherapy as an advance in cancer medicine - Innovations Report
Krebszentrum CIO Bonn - Ich bin Prof. Annkristin Heine | Facebook
Team | IMMEI
Prof. Dr. med. Annkristin Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
